Effects of oxypeucedanin on hKv1.5 and action potential duration

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 4, 2005, Pages 657-660

  Eun, Jae Soon ^a   Park, Jung Ah ^b   Choi, Bok Hee ^b   Cho, Sun Kyung ^a   Kim, Dae Keun ^a   Kwak, Yong Geun ^b  

^a Woosuk University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Angelica dahurica; Antiarrhythmic drug; hKv1.5 channel blocker; Oxypeucedanin

Indexed keywords

ANGELICA DAHURICA EXTRACT; ANGELICA EXTRACT; FUROCOUMARIN DERIVATIVE; OXYPEUCEDANIN; POTASSIUM CHANNEL HERG; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANGELICA; ANGELICA DAHURICA; ANIMAL CELL; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM MUSCLE; HEART MUSCLE POTENTIAL; HEART VENTRICLE WALL; IC 50; MEMBRANE DEPOLARIZATION; MICROELECTRODE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; RAT; VOLTAGE GATED POTASSIUM CHANNEL HKV1.5;

ACTION POTENTIALS; ANGELICA; ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HUMANS; MOLECULAR STRUCTURE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; PSORALENS; RATS;

EID: 21144459096     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.657     Document Type: Article

References (20)

1. Lee W. T., "Coloured Standard Illustrations of Korean Plants," Academy, Seoul, 1996, p. 253.
2. Kimura T., But P. P. H., Guo J. X., Sung C. K., "International Collation of Traditional and Folk Medicine, Part 1," World Scientific, Singapore, 1996, pp. 117-118.
3. Kim D. K., Lim J. P., Yang J. H., Eom D. O., Eun J. S., Leem K. H., Arch. Pharm. Res., 25, 856-859 (2002).
4. Roden D. M., Am. J. Cardiol., 82, 491-571 (1998).
5. Sanguinetti M. C., Keating M. T., News Physiol. Sci., 12, 152-157 (1997).
6. Roden D. M., George A. J., Jr., Annu. Rev. Med., 47, 138-148 (1996).
7. Fedida D., Chen F. S., Zhang X., Can. J. Physiol. Pharmacol., 76, 77-89 (1998).
8. Baek N. I., Ahn E. M., Kim H. Y., Arch. Pharm. Res., 23, 467-470 (2000).
9. Snyders D. J., Knoth K. M., Roberts S. L., Tamkun M. M., Mol. Pharmacol., 41, 322-330 (1992).
10. Snyders D. J., Tamkun M. M., Bennett P. B., J. Gen. Physiol., 101, 513-543 (1993).
11. Grissner S., TiPS, 18, 347-350 (1997).
12. Deal K. K., England S. K., Tamkun M. M., Physiol. Rev., 76, 49-67 (1996).
13. Jeck C. D., Boyden P. A., Circ. Res., 71, 1390-1403 (1992).
14. Wang Z., Fermini B., Nattel S., Cardiovasc. Res., 28, 1540-1546 (1994).
15. Colatsky T. J., Follmer C. H., Starmer C. F., Circulation, 82, 2235-2242 (1990).
16. Roden D. M., Am. J. Cardiol., 72, 44B-49B (1993).
17. Roberds S. L., Tamkun M. M., Proc. Natl. Acad. Sci. U.S.A., 88, 1798-1802 (1991).
18. Dixon J. E., McKinnon D., Circ. Res., 75, 252-260 (1994).
19. Mays D. J., Foose J. M., Philipson L. H., Tamkun M. M., J. Clin. Invest., 96, 282-292 (1995).
20. Valenzuela C., Delpon E., Franqueza L., Gay P., Perez O., Tarmago J., Snyders D. J., Circulation, 94, 562-570 (1996).